Data Management

A high performing team of global data management experts.

Everyone on the MMS team has been so collaborative and responsive. It is rare to have such a seamless experience.
Biometrics Leader
Large Pharmaceutical Partner

Driven by quality, the experts at MMS approach every biometrics deliverable as a top priority, no matter the size or scope of the project. You and your team can expect in-depth, thoughtful conversations with team members, knowing that they are thought leaders, invited speakers, and change makers in industry groups across the globe.

Certified in multiple industry esteemed EDC platforms, allowing for flexible approach to database builds and efficiencies to tailor to Sponsor requirements as projects progress.

Data Management services at MMS are designed to streamline  the process of design, collection, reconciliation, and review of clinical research data. Our clinical data specialists manage all aspects of the data while you stay in complete control — with continuous access to data and total transparency to study progress.

Working with MMS brings:

  • An experienced, award-winning team to manage studies across a variety of industry leading EDC platforms, including accreditations to build in Rave, Zelta, and Medrio
  • Expertise to recommend and deploy cutting-edge “e” technologies, including eCOA (eClinRO and ePRO), eDiary, and eConsent 
  • A wide range of therapeutic area expertise
  • Proven processes to begin clinical studies faster, with accurate, clean results that exceed expectations
  • Near real-time access to clean clinical data, including added visibility via Datacise technology
  • A single point of contact, reducing communication burden and increasing historical knowledge

MMS Clinical Data Managers provide: 

  • Expert knowledge on EDC technology and surrounding processes
  • Clean, reproducible fit-for-analysis data, with cross functional support from the entire biometrics team
  • Lead Data Managers that rise to the challenge of aggressive study timelines
  • Knowledge transfer and industry-leading CRO retention rates increase efficiencies to propel study conduct to the finish line while ensuring data integrity

Suggested For You

perspectives

December 17th, 2024

Oncology Drug Development: Webinar Learnings on the Use of Expedited Pathways and Oncology Center of Excellence Programs

perspectives

December 11th, 2024

Why Emerging Biotech Companies are Increasingly Turning to Specialized Data CROs

regulatory intelligence

December 4th, 2024

FDA Issues Detailed Guidance on Development of Gene Therapy Products

news

December 4th, 2024

AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

perspectives

November 26th, 2024

Finding GRASEland: Navigating the New Regulatory Path for Grandfathered OTC Drugs 

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development